This bill requires the National Institutes of Health to study and report on the neurological impacts of COVID-19 on individuals with a neurological disease.
To direct the Secretary of Health and Human Services, acting through 
 the Director of the National Institutes of Health, to conduct a study 
     on the neurological impacts of COVID-19 on individuals with a 
                         neurological disease.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. STUDY ON THE NEUROLOGICAL IMPACTS OF COVID-19 ON INDIVIDUALS 
              WITH A NEUROLOGICAL DISEASE.

    (a) Study.--The Secretary of Health and Human Services, acting 
through the Director of the National Institutes of Health, shall 
conduct a study on the neurological impacts of COVID-19 on individuals 
with a neurological disease.
    (b) Report.--Not later than 120 days after the date of enactment of 
this Act, the Secretary of Health and Human Services shall complete the 
study under subsection (a) and submit to the Congress a report on the 
results of such study.
                                 <all>
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.
Official Titles - House of Representatives
Official Title as Introduced
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.
Rep. Keating, William R.